Last updated 2026-07-20
- Raised $52M Undisclosed Round, Nov 2018
- Raised $50M Undisclosed Round, Sep 2017
- Raised $50M Undisclosed Round, 2016
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
SGVC, now operating as Group 11, is a venture capital firm founded by Israeli-born Dov Frances. The firm invests in early and growth-stage software companies disrupting the financial services industry, with a strong focus on Israeli-related technology companies. They invest in fintech, wealth tech, insurtech, real estate tech, and adjacent B2B enterprise software.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
2 portfolio exits on record.
Portfolio by sector
Health Tech & Life Sciences1
Fintech & Insurtech1
Q&A
- What are some of SGVC's notable portfolio companies?
- SGVC's portfolio includes Navan, a corporate travel and expense management company, and AID Cann, which focuses on medical cannabis products.
- Has SGVC had any notable exits recently?
- SGVC had an exit with Navan in October 2025, which went public on NASDAQ with a valuation of $6.2 billion.
- What sectors does SGVC's portfolio concentrate on?
- SGVC's portfolio shows concentration in Health Tech & Life Sciences and Fintech & Insurtech sectors.
- When did SGVC have its most recent exit?
- SGVC's most recent exit was in October 2025 with Navan, which became a public company.
- What was the valuation of Navan at its exit?
- Navan, a portfolio company of SGVC, had a valuation of $6.2 billion when it went public on NASDAQ in October 2025.
- Which stock exchange did Navan list on?
- Navan, a company in SGVC's portfolio, listed on NASDAQ during its public offering in October 2025.
- What was the exit event for AID Cann?
- AID Cann, a portfolio company of SGVC, had a public offering event on TASE in September 2009.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2012-1 |
|---|